13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 39 holding rows worth $813,433,000.
- Accession
- 0001172661-22-002484
- Filer
- CIK 1792126
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 39 entries on the cover page, a total value of $813,433,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $813,433,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,300,000 | $88,790,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,700,000 | $82,365,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 4,135,000 | $61,694,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,397,680 | $48,793,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,797,501 | $46,774,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 2,000,000 | $46,520,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 350,000 | $38,689,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 5,936,666 | $36,332,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 150,000 | $33,740,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,525,000 | $29,143,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,287,321 | $29,049,000 | thousands by filing date | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 2,971,352 | $28,436,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,500,000 | $26,910,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 250,000 | $25,815,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 1,085,251 | $22,009,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,000,000 | $20,510,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 500,000 | $18,050,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 350,000 | $16,429,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,950,000 | $15,776,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 400,000 | $13,620,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 850,000 | $11,118,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $10,333,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 950,000 | $9,956,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 750,000 | $9,578,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 800,000 | $8,448,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 950,000 | $8,180,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 510,000 | $5,472,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 2,000,000 | $4,680,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 460,075 | $4,550,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 240,200 | $2,517,000 | thousands by filing date | put |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 205,595 | $1,871,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 399,801 | $1,607,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 331,872 | $1,606,000 | thousands by filing date | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,000,000 | $1,370,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 127,316 | $1,119,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 307,908 | $616,000 | thousands by filing date | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 197,913 | $521,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 220,434 | $434,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $13,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-002484 | this filing | 2022-11-14 | acceptance time not in the bulk data set |